- Tytuł:
- Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability
- Autorzy:
- Źródło:
- In Multiple Sclerosis and Related Disorders December 2023 80
Czasopismo naukowe